Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2020
Period Ending	Aug '25 Aug 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2020
Market Capitalization	3,270	2,913	1,659	1,560	5,270	-	Upgrade
Market Cap Growth	39.47%	75.64%	6.34%	-70.40%	-	-	Upgrade
Enterprise Value	3,212	2,858	1,613	1,535	5,004	-	Upgrade
Last Close Price	26.81	24.21	14.10	13.49	46.56	-	Upgrade
Forward PE	62.31	83.45	89.47	148.08	-	-	Upgrade
PS Ratio	3.97	3.78	2.48	2.61	9.74	-	Upgrade
PB Ratio	9.05	8.57	5.50	5.44	18.43	-	Upgrade
P/TBV Ratio	9.05	8.57	5.50	5.67	19.00	-	Upgrade
P/FCF Ratio	62.44	83.93	226.60	-	-	-	Upgrade
P/OCF Ratio	28.01	29.50	27.20	150.41	-	-	Upgrade
EV/Sales Ratio	3.91	3.71	2.41	2.57	9.25	-	Upgrade
EV/EBITDA Ratio	99.41	165.53	-	-	-	-	Upgrade
EV/FCF Ratio	61.33	82.35	220.35	-	-	-	Upgrade
Debt / Equity Ratio	0.63	0.66	0.58	0.61	-	-	Upgrade
Debt / EBITDA Ratio	3.24	4.26	99.58	-	-	-	Upgrade
Debt / FCF Ratio	4.36	6.49	23.83	-	-	-	Upgrade
Asset Turnover	1.24	1.23	1.17	1.19	1.22	1.27	Upgrade
Inventory Turnover	7.74	6.01	4.65	4.08	4.67	4.84	Upgrade
Quick Ratio	2.12	1.97	1.72	1.62	2.18	2.99	Upgrade
Current Ratio	2.55	2.50	2.35	2.27	2.78	3.42	Upgrade
Return on Equity (ROE)	-2.67%	-6.35%	-21.48%	-38.56%	-48.54%	-29.29%	Upgrade
Return on Assets (ROA)	-1.56%	-2.84%	-7.48%	-13.38%	-16.24%	-11.21%	Upgrade
Return on Capital (ROIC)	-1.86%	-3.43%	-9.18%	-18.10%	-24.19%	-18.21%	Upgrade
Earnings Yield	-0.28%	-0.70%	-3.81%	-7.08%	-2.74%	-	Upgrade
FCF Yield	1.60%	1.19%	0.44%	-3.19%	-1.53%	-	Upgrade
Buyback Yield / Dilution	-2.31%	-2.55%	-2.13%	-61.32%	-34.35%	-1.16%	Upgrade

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q